Corvus Pharmaceuticals, Inc. Other Comprehensive Income (Loss), Net of Tax
Corvus Pharmaceuticals, Inc. (CRVS) reported Other Comprehensive Income (Loss), Net of Tax of -$36.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Income Statement
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2016-11-03
- Corvus Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-09-30 was -$36.00K, a 3700.00% decline year-over-year.
- Corvus Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-06-30 was $49.00K.
- Corvus Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2016-03-31 was $74.00K.
- Corvus Pharmaceuticals, Inc. other comprehensive income (loss), net of tax for the quarter ending 2015-09-30 was $1.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|---|
| 2016-09-30 | -$36.00K 10-Q · filed 2016-11-03 | $13.00K derived: sum of 2 quarters · filed 2016-11-03 | $86.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $49.00K 10-Q · filed 2016-08-04 | $123.00K 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $74.00K 10-Q · filed 2016-05-05 | ||
| 2015-09-30 | $1.00K 10-Q · filed 2016-11-03 | $3.00K 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |